Form 4: ANI Pharmaceuticals Executive Meredith Cook Sells 250 Shares
SEC Filing
Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, sold 250 shares of common stock at $57.19 per share on October 14, 2024, according to a Form 4 filing.
Summary
- On October 14, 2024, Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, sold 250 shares of common stock.
- The sale was executed at a price of $57.19 per share.
- Following the transaction, Cook directly owns 56,488 shares of ANI Pharmaceuticals.
- The sale was conducted under a Rule 10b5-1 trading plan adopted on August 11, 2023.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction was pre-planned under a Rule 10b5-1 trading plan and doesn't necessarily reflect a change in the executive's outlook on the company.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| August 11, 2023 | Date of adoption of Rule 10b5-1 trading plan |
| October 14, 2024 | Date of transaction (stock sale) |
| October 15, 2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.